CALC

CalciMedica (CALC)

About CalciMedica (CALC)

CalciMedica, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. The firm's product candidate, Auxora, helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.

Details

Daily high
$0.67
Daily low
$0.60
Price at open
$0.62
52 Week High
$7.20
52 Week Low
$0.46
Market cap
10.2M
Dividend yield
0.00%
Volume
158,869
Avg. volume
513,015
P/E ratio
-.33

CalciMedica News

Details

Daily high
$0.67
Daily low
$0.60
Price at open
$0.62
52 Week High
$7.20
52 Week Low
$0.46
Market cap
10.2M
Dividend yield
0.00%
Volume
158,869
Avg. volume
513,015
P/E ratio
-.33